Literature DB >> 19429674

IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes.

Jan Christiansen1, Astrid M Kolte, Thomas v O Hansen, Finn C Nielsen.   

Abstract

Recent genome-wide association (GWA) studies of type 2 diabetes (T2D) have implicated IGF2 mRNA-binding protein 2 (IMP2/IGF2BP2) as one of the several factors in the etiology of late onset diabetes. IMP2 belongs to a family of oncofetal mRNA-binding proteins implicated in RNA localization, stability, and translation that are essential for normal embryonic growth and development. This review provides a background to the IMP protein family with an emphasis on human IMP2, followed by a closer look at the GWA studies to evaluate the significance, if any, of the proposed correlation between IMP2 and T2D.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19429674     DOI: 10.1677/JME-09-0016

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  83 in total

Review 1.  Lin28 and let-7 in cell metabolism and cancer.

Authors:  Liem H Nguyen; Hao Zhu
Journal:  Transl Pediatr       Date:  2015-01

Review 2.  Characteristics of circular RNAs generated by human Survival Motor Neuron genes.

Authors:  Eric W Ottesen; Ravindra N Singh
Journal:  Cell Signal       Date:  2020-06-15       Impact factor: 4.315

Review 3.  Regulation of β-cell function by RNA-binding proteins.

Authors:  Maria Grazia Magro; Michele Solimena
Journal:  Mol Metab       Date:  2013-09-25       Impact factor: 7.422

4.  The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.

Authors:  Stephan Laggai; Sonja M Kessler; Stefan Boettcher; Valérie Lebrun; Katja Gemperlein; Eva Lederer; Isabelle A Leclercq; Rolf Mueller; Rolf W Hartmann; Johannes Haybaeck; Alexandra K Kiemer
Journal:  J Lipid Res       Date:  2014-04-22       Impact factor: 5.922

Review 5.  The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers.

Authors:  Jinyan Wang; Lijuan Chen; Ping Qiang
Journal:  Cancer Cell Int       Date:  2021-02-10       Impact factor: 5.722

6.  IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes.

Authors:  S Rodriguez; G Eiriksdottir; T R Gaunt; T B Harris; L J Launer; V Gudnason; I N M Day
Journal:  Growth Horm IGF Res       Date:  2010-08       Impact factor: 2.372

7.  Synthesizing genome-wide association studies and expression microarray reveals novel genes that act in the human growth plate to modulate height.

Authors:  Julian C Lui; Ola Nilsson; Yingleong Chan; Cameron D Palmer; Anenisia C Andrade; Joel N Hirschhorn; Jeffrey Baron
Journal:  Hum Mol Genet       Date:  2012-08-21       Impact factor: 6.150

8.  IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population.

Authors:  Qiong Huang; Ji-ye Yin; Xing-ping Dai; Qi Pei; Min Dong; Zhi-guang Zhou; Xi Huang; Min Yu; Hong-hao Zhou; Zhao-qian Liu
Journal:  Acta Pharmacol Sin       Date:  2010-06       Impact factor: 6.150

9.  NetCore: a network propagation approach using node coreness.

Authors:  Gal Barel; Ralf Herwig
Journal:  Nucleic Acids Res       Date:  2020-09-25       Impact factor: 16.971

10.  Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway.

Authors:  Zhizhong Li; Yunyu Zhang; Krishnan Ramanujan; Yan Ma; David G Kirsch; David J Glass
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.